Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Operating Expenses | -2,246 | -3,010 | 1,220 | 7,174 | 10,392 |
| Operating Income | 2,246 | 3,010 | -1,220 | -7,174 | -10,392 |
| Other Income | 36 | 88 | 890 | 134 | 155 |
| Pre-tax Income | 2,282 | 3,098 | -330 | -7,040 | -10,237 |
| Income Tax | 535 | 682 | -63 | -238 | -1,650 |
| Net Income Continuous | 1,747 | 2,416 | -267 | -6,802 | -8,587 |
| Net Income Discontinuous | N/A | N/A | 15,955 | 608 | -1,094 |
| Net Income | $1,747 | $2,416 | $15,688 | $-6,194 | $-9,681 |
| EPS Basic Total Ops | 0.05 | 0.07 | 0.49 | -0.19 | -0.30 |
| EPS Basic Continuous Ops | 0.05 | 0.07 | -0.01 | -0.21 | -0.26 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.48 | 0.02 | -0.03 |
| EPS Diluted Total Ops | 0.05 | 0.07 | 0.49 | -0.19 | -0.30 |
| EPS Diluted Continuous Ops | 0.05 | 0.07 | -0.01 | -0.21 | -0.26 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.48 | 0.02 | -0.03 |
| EBITDA(a) | $2,434 | $3,200 | $-1,038 | $-6,996 | $-10,214 |